North America Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

98 pages | Grace Market Data
North America digital respiratory solutions market is expected to grow by 34.4% annually in the forecast period and reach $155.05 million by 2030 driven by the rising demand for respiratory aids and air purification amid COVID-19 pandemic.
Highlighted with 24 tables and 39 figures, this 98-page report “North America Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Therapeutic Devices
• Inhalers
• Nebulizers
Diagnostic Devices
• Spirometers
• Asthma Monitors
• Other Diagnostic Devices
Sensors and Apps

Based on Indication, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• COVID-19 Caused Diseases
• Other Diseases

Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
3M Health Care Limited
Adherium Limited
Amiko Digital Health Limited
AsthmaMD
AstraZeneca plc
Boehringer Ingelheim International GmbH
Capsule Technologies, Inc.
Cohero Health
GlaxoSmithKline plc
Kaia Health Software GmbH
Medical International Research (MIR)
Novartis AG
NuvoAir
Reciprocal Labs (Propeller Health)
Sensiron AG
Tactio Health
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 5

1.1 Industry Definition and Research Scope 5

1.1.1 Industry Definition 5

1.1.2 Research Scope 6

1.2 Research Methodology 9

1.2.1 Overview of Market Research Methodology 9

1.2.2 Market Assumption 10

1.2.3 Secondary Data 10

1.2.4 Primary Data 10

1.2.5 Data Filtration and Model Design 12

1.2.6 Market Size/Share Estimation 13

1.2.7 Research Limitations 14

1.3 Executive Summary 15

2 Market Overview and Dynamics 17

2.1 Market Size and Forecast 17

2.1.1 Impact of COVID-19 on the Market 18

2.2 Major Growth Drivers 20

2.3 Market Restraints and Challenges 25

2.4 Emerging Opportunities and Market Trends 28

2.5 Porter’s Fiver Forces Analysis 32

3 Segmentation of North America Market by Product Type 37

3.1 Market Overview by Product Type 37

3.2 Therapeutic Devices 39

3.2.1 Inhalers 40

3.2.2 Nebulizers 41

3.3 Diagnostic Devices 42

3.3.1 Spirometers 44

3.3.2 Asthma Monitors 45

3.3.3 Other Diagnostic Devices 46

3.4 Sensors and Apps 47

4 Segmentation of North America Market by Indication 48

4.1 Market Overview by Indication 48

4.2 Asthma 50

4.3 Chronic Obstructive Pulmonary Disease (COPD) 51

4.4 COVID-19 Caused Diseases 52

4.5 Other Diseases 53

5 Segmentation of North America Market by Distribution Channel 54

5.1 Market Overview by Distribution Channel 54

5.2 Hospital Pharmacies 56

5.3 Retail Pharmacies 57

5.4 Online Pharmacies 58

6 North America Market 2019-2030 by Country 59

6.1 Overview of North America Market 59

6.2 U.S. 62

6.3 Canada 66

6.4 Mexico 68

7 Competitive Landscape 70

7.1 Overview of Key Vendors 70

7.2 New Product Launch, Partnership, Investment, and M&A 73

7.3 Company Profiles 74

3M Health Care Limited 74

Adherium Limited 76

Amiko Digital Health Limited 77

AsthmaMD 78

AstraZeneca plc 79

Boehringer Ingelheim International GmbH 80

Capsule Technologies, Inc. 81

Cohero Health 82

GlaxoSmithKline plc 83

Kaia Health Software GmbH 84

Medical International Research (MIR) 85

Novartis AG 86

NuvoAir 87

Reciprocal Labs (Propeller Health) 88

Sensiron AG 89

Tactio Health 90

Teva Pharmaceuticals Industries Ltd. 91

8 Investing in North America Market: Risk Assessment and Management 92

8.1 Risk Evaluation of North America Market 92

8.2 Critical Success Factors (CSFs) 95

Related Reports and Products 98



Table 1. Snapshot of North America Digital Respiratory Solutions Market, 2019-2030 16

Table 2. Main Product Trends and Market Opportunities in North America Digital Respiratory Solutions Market 28

Table 3. North America Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 37

Table 4. North America Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn 39

Table 5. North America Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn 43

Table 6. North America Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 48

Table 7. North America Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 54

Table 8. North America Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 60

Table 9. U.S. Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 64

Table 10. U.S. Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 64

Table 11. U.S. Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 64

Table 12. Canada Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 67

Table 13. Canada Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 67

Table 14. Canada Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 67

Table 15. Mexico Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 69

Table 16. Mexico Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 69

Table 17. Mexico Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 69

Table 18. 3M Health Care Limited: Company Snapshot 74

Table 19. 3M Health Care Limited: Business Segmentation 74

Table 20. 3M Health Care Limited: Product Portfolio 75

Table 21. 3M Health Care Limited: Revenue, 2016-2018, $ mn 75

Table 22. 3M Health Care Limited: Recent Developments 75

Table 23. Risk Evaluation for Investing in North America Market, 2019-2030 93

Table 24. Critical Success Factors and Key Takeaways 96



Figure 1. Research Method Flow Chart 9

Figure 2. Breakdown of Primary Research 11

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 13

Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 15

Figure 5. North America Digital Respiratory Solutions Market, 2019-2030, $ mn 17

Figure 6. Primary Drivers and Impact Factors of North America Digital Respiratory Solutions Market 20

Figure 7. GDP per capita in the World, 1960-2018, $ thousand 23

Figure 8. Forecast of Middle-class Population by Region, 2015-2030, million 23

Figure 9. Worldwide Connected Devices by Device Type, 2014-2022, billion units 24

Figure 10. Primary Restraints and Impact Factors of North America Digital Respiratory Solutions Market 25

Figure 11. Investment Opportunity Analysis 29

Figure 12. Porter’s Fiver Forces Analysis of North America Digital Respiratory Solutions Market 32

Figure 13. Breakdown of North America Digital Respiratory Solutions Market by Product Type, 2019-2030, % of Sales Revenue 37

Figure 14. North America Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%) 38

Figure 15. North America Digital Respiratory Solutions Market: Therapeutic Devices, 2019-2030, $ mn 39

Figure 16. North America Digital Respiratory Solutions Market: Inhalers, 2019-2030, $ mn 40

Figure 17. North America Digital Respiratory Solutions Market: Nebulizers, 2019-2030, $ mn 41

Figure 18. North America Digital Respiratory Solutions Market: Diagnostic Devices, 2019-2030, $ mn 42

Figure 19. North America Digital Respiratory Solutions Market: Spirometers, 2019-2030, $ mn 44

Figure 20. North America Digital Respiratory Solutions Market: Asthma Monitors, 2019-2030, $ mn 45

Figure 21. North America Digital Respiratory Solutions Market: Other Diagnostic Devices, 2019-2030, $ mn 46

Figure 22. North America Digital Respiratory Solutions Market: Sensors and Apps, 2019-2030, $ mn 47

Figure 23. Breakdown of North America Digital Respiratory Solutions Market by Indication, 2019-2030, % of Sales Revenue 49

Figure 24. North America Addressable Market Cap in 2020-2030 by Indication, Value ($ mn) and Share (%) 49

Figure 25. North America Digital Respiratory Solutions Market: Asthma, 2019-2030, $ mn 50

Figure 26. North America Digital Respiratory Solutions Market: Chronic Obstructive Pulmonary Disease (COPD), 2019-2030, $ mn 51

Figure 27. North America Digital Respiratory Solutions Market: COVID-19 Caused Diseases, 2019-2030, $ mn 52

Figure 28. North America Digital Respiratory Solutions Market: Other Diseases, 2019-2030, $ mn 53

Figure 29. Breakdown of North America Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, % of Revenue 55

Figure 30. North America Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%) 55

Figure 31. North America Digital Respiratory Solutions Market: Hospital Pharmacies, 2019-2030, $ mn 56

Figure 32. North America Digital Respiratory Solutions Market: Retail Pharmacies, 2019-2030, $ mn 57

Figure 33. North America Digital Respiratory Solutions Market: Online Pharmacies, 2019-2030, $ mn 58

Figure 34. Breakdown of North America Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 60

Figure 35. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 61

Figure 36. U.S. Digital Respiratory Solutions Market, 2019-2030, $ mn 63

Figure 37. Canada Digital Respiratory Solutions Market, 2019-2030, $ mn 66

Figure 38. Digital Respiratory Solutions Market in Mexico, 2015-2030, $ mn 68

Figure 39. Growth Stage of North America Digital Respiratory Solutions Industry over the Forecast Period 70

Enquire before buy

relatedReports

Purchase this Report
Please select buying option
Single User $2800
Multi User $3900
Enterprise $5100

Newsletters Signup

Sign up to Our Newsletter & get attractive Offers by subscribing to our newsletters.

Thank you for suscrbing!